search
Back to results

Multimodal Imaging in Central Serous Chorioretinopathy (IMO)

Primary Purpose

Central Serous Chorioretinopathy

Status
Terminated
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
RTX1 IMAGIN EYE retinal camera
Sponsored by
Centre Hospitalier Universitaire de Besancon
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Central Serous Chorioretinopathy focused on measuring Optical Coherence Tomography, Retinal camera

Eligibility Criteria

18 Years - 60 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Signed informed consent form
  • Beneficiary/affiliated to French social security/social healthcare
  • Active ou chronic Central Serous Chorioretinopathy on at least one eye
  • Absence of other known ophthalmological pathology or of any ophthalmological conditions revealed during the examination

Exclusion Criteria:

  • Legal incapacity or limited legal capacity
  • Predictable poor adherence
  • Subject without health insurance
  • Pregnant or breatfeeding women
  • Sujet étant dans la période d'exclusion d'une autre étude ou prévue par le "fichier national des volontaires"
  • Presence of transparent medium opacity damaging images quality
  • Previous photosensitivity
  • Recent treatment with PhotoDynamic Therapy (PDT)
  • Use of drugs inducing photosensitivity

Sites / Locations

  • CHU Besançon

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Adaptative optics retinal camera

Arm Description

Outcomes

Primary Outcome Measures

Workability of images of RTX1 IMAGIN EYE retinal camera
Two readings of the images captured with adaptative optics retinal camera and assessment of their workability in routine care.

Secondary Outcome Measures

Full Information

First Posted
August 31, 2016
Last Updated
September 13, 2019
Sponsor
Centre Hospitalier Universitaire de Besancon
search

1. Study Identification

Unique Protocol Identification Number
NCT02889185
Brief Title
Multimodal Imaging in Central Serous Chorioretinopathy
Acronym
IMO
Study Type
Interventional

2. Study Status

Record Verification Date
September 2019
Overall Recruitment Status
Terminated
Study Start Date
April 2016 (undefined)
Primary Completion Date
December 4, 2018 (Actual)
Study Completion Date
December 4, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Centre Hospitalier Universitaire de Besancon

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
This study aims to assess the contribution of the multimodal imaging, combining a routine examination using Optical Coherence Tomography (OCT) with an imaging procedure using adaptive optics retinal camera. This is a feasibility study with a limited number of patients.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Central Serous Chorioretinopathy
Keywords
Optical Coherence Tomography, Retinal camera

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
3 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Adaptative optics retinal camera
Arm Type
Experimental
Intervention Type
Device
Intervention Name(s)
RTX1 IMAGIN EYE retinal camera
Intervention Description
In addition to the routine examination including OCT, an imaging using RTX1 IMAGIN EYE retinal camera will be performed.
Primary Outcome Measure Information:
Title
Workability of images of RTX1 IMAGIN EYE retinal camera
Description
Two readings of the images captured with adaptative optics retinal camera and assessment of their workability in routine care.
Time Frame
day 1

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Signed informed consent form Beneficiary/affiliated to French social security/social healthcare Active ou chronic Central Serous Chorioretinopathy on at least one eye Absence of other known ophthalmological pathology or of any ophthalmological conditions revealed during the examination Exclusion Criteria: Legal incapacity or limited legal capacity Predictable poor adherence Subject without health insurance Pregnant or breatfeeding women Sujet étant dans la période d'exclusion d'une autre étude ou prévue par le "fichier national des volontaires" Presence of transparent medium opacity damaging images quality Previous photosensitivity Recent treatment with PhotoDynamic Therapy (PDT) Use of drugs inducing photosensitivity
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Maher Saleh, MD PhD
Organizational Affiliation
CHU Besançon
Official's Role
Principal Investigator
Facility Information:
Facility Name
CHU Besançon
City
Besançon
ZIP/Postal Code
25000
Country
France

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Multimodal Imaging in Central Serous Chorioretinopathy

We'll reach out to this number within 24 hrs